Post-Doctoral Research Fellow, Brigham and Women's Hospital
BIOGRAPHY
OCT 02, 2024 8:00 AM PDT
Unveiling Novel Biomarkers and their Spatial Distribution within the Tumor Microenvironment of Renal Cell Carcinoma Using the BOND RX and Image Analysis Workflow
Speaker
Event Date & Time
Date: October 2, 2024
Time: 8:00 AM PDT, 10:00 AM CDT, 11:00 AM EDT
Abstract
In this webinar, discover how Dr El Ahmar utilizes the BOND RX autostainer and image analysis workflow to stain formalin-fixed paraffin-embedded (FFPE) clinical trial samples with multiplex immunofluorescent assays. The aim is to reveal predictive biomarkers for response and resistance to immunotherapy and analyze their spatial distribution within the tumor microenvironment of renal cell carcinoma.
Dr El Ahmar will be presenting published laboratory work.
Learning Objectives
- Learn how academic labs are utilizing the BOND RX to understand the tumor microenvironment and find predictive biomarkers in Renal Cell Carcinoma
- See how researchers optimize multiplex immunofluorescent panels on the BOND RX using Opal
- Review 3 independent clinical trials on biomarker response to anti-PD-1 monotherapy
FOR RESEARCH USE ONLY.
Not For Use In Diagnostic Procedures. Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...